NCT06653517: Clinical Study of Neoadjuvant Targeted Therapy for Ameloblastoma
- State
- Under way
- Phase
- Phase 2
- People
- 12 planned
- Started
- 1 Jan 2023
- Primary completion
- 31 Dec 2026
- Arms
- Dabrafenib and Trametinib Treatment Arm
- Results
- None posted
- 1 Jan 2023: Trial started
- 22 Oct 2024: Trial registered